| Literature DB >> 36014493 |
Xiaojing Si1, Mei Han1, Hongyan Zeng2, Xiaoyi Wei1.
Abstract
OBJECTIVE: A sensitive and selective fluorescence-detection platform based on carbon quantum dots (CQDs) was designed and developed for the determination of methotrexate (MTX), for the purpose of minimizing the possible toxic threat of MTX in clinics.Entities:
Keywords: carbon quantum dots; fluorescence; methotrexate; polyvinyl imine
Mesh:
Substances:
Year: 2022 PMID: 36014493 PMCID: PMC9415630 DOI: 10.3390/molecules27165254
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1The structure of branched PEI.
Figure 2(A) TEM image of the synthesized PEI-CQDs; (B) PEI-CQDs’ particle-size distribution; (C) XRD pattern of PEI-CQDs.
Figure 3FT-IR spectrum of the PEI-CQDs.
Figure 4UV−vis and PL absorption spectra of PEI-CQDs.
Figure 5Effect of pH (A) and volume (B) of PEI-CQDs on the fluorescence intensity of the detection system.
Figure 6(A) Fluorescence-intensity curves of MTX with different concentrations; (B) Linear relation curve of log (F0/F) and concentration of MTX.
Comparison of major characteristics for MTX with other published methods.
| Method | Linear Range | Detection Limit | References |
|---|---|---|---|
| N,S-CQDs | 0.4–41.3 μg/mL | 12 ng/mL | [ |
| CE | 0.5–10 μmol/L | 0.1 μmol/L | [ |
| SPRS | 0–150 μmol/L | 0.6 μmol/L | [ |
| UPLC-MS-MS | 1.0–100μmol/L | 0.16μmol/L | [ |
| chemiluminescence immunoassay | 4.3–392.8 ng/mL | 9.1 ng/mL | [ |
| Electrochemical sensor | 0.005–7 μmol/L | 3.07 nmol/L | [ |
| Flow-injection–electrochemical oxidation fluorimetry | 2.0 × 10−7–1.0 × 10−5 g/mL | 5.2 × 10−8 g/mL | [ |
| PEI-CQDs | 1–600 μmol/L | 0.33 μmol/L | This work |
Interference of different substances on the determination of methotrexate.
| Interfering Substance | Concentration (μmol/L) | Current Ratio % |
|---|---|---|
| NaCl | 2500 | 98.54 |
| KNO3 | 5000 | 100.81 |
| CH3COONH4 | 5000 | 100.81 |
| K2SO4 | 2500 | 100.31 |
| Glycine | 2500 | 101.74 |
| Phenylalanine | 2500 | 102.52 |
| Histidine | 2500 | 103.18 |
| Lysine | 2500 | 104.33 |
| Ascorbic acid | 5000 | 101.99 |
Determination results of MTX in the pharmaceutical product (n = 5).
| No. | Detected (μmol/L) | Detected (mg/Piece) | Labeled | Labeled Quantity (%) | Average (%) | RSD |
|---|---|---|---|---|---|---|
| 1 | 5.86 | 2.44 | 2.5 | 97.6 | 98.2 | 4.4 |
| 2 | 6.04 | 2.51 | 100.4 | |||
| 3 | 6.23 | 2.59 | 103.6 | |||
| 4 | 5.52 | 2.30 | 92.0 | |||
| 5 | 5.83 | 2.43 | 97.2 |
MTX standard recovery (n = 5).
| No. | Sample | Added | Total | Recovery (%) | Average | RSD |
|---|---|---|---|---|---|---|
| 1 | 5.90 | 100 | 107.9 | 102.0 | 100.9 | 0.9 |
| 2 | 106.2 | 100.3 | ||||
| 3 | 106.8 | 100.9 | ||||
| 4 | 107.5 | 101.6 | ||||
| 5 | 105.6 | 99.7 |